Latest Stories
SMPL Q4 CY2025 Deep Dive: Quest and OWYN Power Growth as Margin Pressure Persists
Packaged food company Simply Good Foods (NASDAQ:SMPL) reported Q4 CY2025 results exceeding the market’s revenue expectations, but sales were flat year on year at $340.2 million. Its non-GAAP profit of $0.39 per share was 8.2% above analysts’ consensus estimates.
STZ Q4 Deep Dive: Margin Pressures and Distribution Gains Shape Outlook
Beer, wine, and spirits company Constellation Brands (NYSE:STZ) reported Q4 CY2025 results exceeding the market’s revenue expectations, but sales fell by 9.8% year on year to $2.22 billion. Its non-GAAP profit of $3.06 per share was 16.2% above analysts’ consensus estimates.
LNN Q4 Deep Dive: International Projects and Infrastructure Offset Irrigation Headwinds
Agricultural and farm machinery company Lindsay (NYSE:LNN) missed Wall Street’s revenue expectations in Q4 CY2025, with sales falling 6.3% year on year to $155.8 million. Its non-GAAP profit of $1.54 per share was 4.4% above analysts’ consensus estimates.
SNX Q4 Deep Dive: Growth in Cloud and AI Infrastructure Offsets Margin Stability Concerns
IT distribution giant TD SYNNEX (NYSE:SNX) reported revenue ahead of Wall Streets expectations in Q4 CY2025, with sales up 9.7% year on year to $17.38 billion. The company expects next quarter’s revenue to be around $15.5 billion, close to analysts’ estimates. Its non-GAAP profit of $3.83 per share was 2.7% above analysts’ consensus estimates.
AYI Q4 Deep Dive: Backlog-Driven Growth Meets Margin Pressures Amid Tepid Market
Intelligent lighting and space solutions provider Acuity Brands (NYSE:AYI) met Wall Streets revenue expectations in Q4 CY2025, with sales up 20.2% year on year to $1.14 billion. Its non-GAAP profit of $4.69 per share was 2.2% above analysts’ consensus estimates.
WDFC Q4 Deep Dive: Flat Sales and Soft Guidance Amid Distribution Headwinds
Household products company WD-40 (NASDAQ:WDFC) met Wall Streets revenue expectations in Q4 CY2025, but sales were flat year on year at $154.4 million. On the other hand, the company’s full-year revenue guidance of $642.5 million at the midpoint came in 1% below analysts’ estimates. Its GAAP profit of $1.28 per share was 11.4% below analysts’ consensus estimates.
NEOG Q4 Deep Dive: Operational Improvements and New Leadership Drive Upbeat Outlook
Life sciences company Neogen (NASDAQ:NEOG) reported Q4 CY2025 results topping the market’s revenue expectations, but sales fell by 2.8% year on year to $224.7 million. The company’s full-year revenue guidance of $850 million at the midpoint came in 2.8% above analysts’ estimates. Its non-GAAP profit of $0.10 per share was 50% above analysts’ consensus estimates.
1 Services Stock to Target This Week and 2 We Turn Down
Business services providers play a critical role for enterprises, assisting them with everything from new hardware integrations to consulting and marketing. But increasing competition from AI-driven upstarts has tempered enthusiasm, limiting the industry’s gains to 5.4% over the past six months. This return lagged the S&P 500’s 10.5% climb.
1 Large-Cap Stock to Keep an Eye On and 2 We Turn Down
Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new areas for growth is much harder than for smaller, more agile players.
1 Unpopular Stock That Deserves Some Love and 2 That Underwhelm
Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory.